NAA10 anticorps (AA 135-167)

N° du produit ABIN5533721

Détail du produit anti-NAA10 anticorps

Antigène: NAA10 (ARD1A) (ARD1 Homolog, N-Acetyltransferase (ARD1A))

Épitope: AA 135-167

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAA10 est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This NAA10 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 135-167 amino acids from the Central region of human NAA10.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur NAA10

Antigène: NAA10 (ARD1A) (ARD1 Homolog, N-Acetyltransferase (ARD1A))

Autre désignation: NAA10 (ARD1A Produits)

Synonymes: anticorps ARD1, anticorps ARD1A, anticorps DXS707, anticorps NATD, anticorps TE2, anticorps 2310039H09Rik, anticorps Ard1, anticorps Ard1a, anticorps Te2, anticorps RGD1565315, anticorps N(alpha)-acetyltransferase 10, NatA catalytic subunit, anticorps NAA10, anticorps Naa10

Sujet: Catalytic subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Without NAA15, displays epsilon (internal) acetyltransferase activity towards HIF1A, thereby promoting its degradation. Represses MYLK kinase activity by acetylation, and thus represses tumor cell migration. Acetylates, and stabilizes TSC2, thereby repressing mTOR activity and suppressing cancer development.

Poids moléculaire: 26 kDa

ID gène: 8260

UniProt: P41227